TONIX Pharmaceuticals to Present at the New York Society of Security Analysts’ 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011 November 21, 2011 • 6:05 AM EST
Tonix Pharmaceuticals Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 For Fibromyalgia November 18, 2011 • 7:30 AM EST
Tamandare Explorations Inc. Announces Name Change to Tonix Pharmaceuticals Holding Corp. October 20, 2011 • 9:00 AM EDT
TONIX Pharmaceuticals and Tamandare Explorations Announce Completion of Share Exchange Transaction and Private Placement October 14, 2011 • 9:00 AM EDT
Tonix Pharmaceuticals' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology September 7, 2011 • 9:00 AM EDT
Tonix Pharmaceuticals Elects Harvey Moldofsky, M.D., to its Scientific Advisory Board June 20, 2011 • 9:00 AM EDT
TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome June 16, 2011 • 9:00 AM EDT